Literature DB >> 3921626

Effect of human recombinant alpha-2- and gamma-interferon on the growth of human cell lines from solid tumors and hematologic malignancies.

H Denz, M Lechleitner, C Marth, G Daxenbichler, G Gastl, H Braunsteiner.   

Abstract

We studied the growth effects of human recombinant interferon (IFN)-alpha-2 and -gamma on various human cell lines. Four cell lines from solid tumors (WiDr, CCL 185, BT 20, KB) and three cell lines from hematologic malignancies (U 937, U 266, MOLT 4) were chosen. The study was performed using two different assays: (1) a soft agar cloning assay, and (2) a monolayer and suspension culture. In the soft agar assay alpha-IFN inhibited colony growth of 6/6 lines tested (the line MOLT 4 could not be plated); in the monolayer assay it inhibited proliferation of 6/7 lines tested. Gamma-IFN showed inhibitory effects on 5/6 cell lines tested in the soft agar assay, but on one line (CCL 185) low concentrations of gamma-IFN led to a significant increase in the number of colonies. Using the monolayer assay, gamma-IFN showed inhibition of 6/7 lines tested, whereas a stimulation of growth could not be observed. With a combination of alpha- and gamma-IFN, synergistic effects were seen on a histiocytic cell line (U 937) in both assays and a marginal synergism on the T-cell line MOLT 4 in the monolayer assay.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921626     DOI: 10.1089/jir.1985.5.147

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  14 in total

1.  Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro.

Authors:  P Del Monte; C Laurino; M Arvigo; C Palermo; F Minuto; A Barreca
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

2.  Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia.

Authors:  O Kloke; R Becher; N Niederle
Journal:  Blut       Date:  1987-11

Review 3.  Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy.

Authors:  Lisheng Ge; Neil T Hoa; Zechariah Wilson; Gabriel Arismendi-Morillo; Xiao-Tang Kong; Rajeev B Tajhya; Christine Beeton; Martin R Jadus
Journal:  Int Immunopharmacol       Date:  2014-07-12       Impact factor: 4.932

Review 4.  Alpha interferon: a look to the future.

Authors:  E M Bonnem
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

5.  [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].

Authors:  N Niederle; C Doberauer; O Kloke; K Höffken; C G Schmidt
Journal:  Klin Wochenschr       Date:  1987-07-15

6.  Inhibition of tumor cell growth by interferon-gamma is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide.

Authors:  T M Aune; S L Pogue
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

7.  Small cell lung cancer cells express the late stage gBK tumor antigen: a possible immunotarget for the terminal disease.

Authors:  Neil T Hoa; Lisheng Ge; Rajeev B Tajhya; Christine Beeton; Andrew N Cornforth; Amir Abolhoda; Nils Lambrecht; Maria DaCosta-Iyer; Yi Ouyang; Anthony P Mai; Erin Hong; Judy Shon; Michelle J Hickey; Kate L Erickson; Carol A Kruse; Martin R Jadus
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

8.  Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.

Authors:  J E Macheledt; A U Buzdar; G N Hortobagyi; D K Frye; J U Gutterman; F A Holmes
Journal:  Breast Cancer Res Treat       Date:  1991-08       Impact factor: 4.872

9.  Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells.

Authors:  G Sica; F Iacopino; G Robustelli della Cuna; P Marchetti; L Marini
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

10.  Heterogeneous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI).

Authors:  S J Bell; D A Cooper; B E Kemp; R R Doherty; R Penny
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.